Conference Coverage
Conference Coverage
Varenicline Plus Counseling Elevates Smoking Quit Rate
Conference Coverage
Azacitidine-Gemtuzumab Combo Effective in Good-Risk AML
Major Finding: A combination of azacitidine and gemtuzumab followed by azacitidine maintenance produced a 44% complete or near-complete remission...
Conference Coverage
VTE Risk Pumped Up in Rheumatoid Arthritis
Major Finding: The risk of venous thromboembolism was 40% greater in RA patients than controls in one 2-year study, whereas a second study found...
Conference Coverage
Tocilizumab Beats Adalimumab in Monotherapy RA Trial
Conference Coverage
Ixekizumab Normalizes Mutant Psoriasis Genes
Major Finding: Ixekizumab resulted in a greater-than-75% normalization of expression of 643 inflammatory genes, compared with 104 with etanercept...
Conference Coverage
Some Antidepressants Increased Risk of Death in ICU
Conference Coverage
Small Study: Reduced Anti-TNF Dose Still Effective
Major Finding: Among patients in remission with chronic rheumatoid disease, a scaled-back anti–tumor necrosis factor dosage remained effective in...
Conference Coverage
Novel Progestin Nestorone, Testosterone Promising as Transdermal Male Contraceptive
Major Finding: Sperm concentrations fell to 1 million/mL after 20-24 weeks of daily gel application in 23% on testosterone plus placebo, 89% on...
Conference Coverage
With Testosterone Replacement, Men Shed Pounds
Major Finding: Long-term testosterone replacement therapy led to an average 36-pound weight loss and 3.5-inch reduction in waist circumference in...